Runnymede Capital Advisors, Inc. Johnson & Johnson Transaction History
Runnymede Capital Advisors, Inc.
- $114 Billion
- Q4 2024
A detailed history of Runnymede Capital Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 260 shares of JNJ stock, worth $40,593. This represents 0.03% of its overall portfolio holdings.
Number of Shares
260Holding current value
$40,593% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding JNJ
# of Institutions
4,369Shares Held
1.69BCall Options Held
16.7MPut Options Held
13.8M-
Vanguard Group Inc Valley Forge, PA233MShares$36.3 Billion0.6% of portfolio
-
Black Rock Inc. New York, NY198MShares$30.9 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$21 Billion0.9% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.76 Billion0.75% of portfolio
-
Morgan Stanley New York, NY45.2MShares$7.05 Billion0.54% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $408B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...